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rosine kinase isoforms (Ret51) and they are characterized by a
‘‘HSCR-like’’ phenotype. In parallel studies, we have developed
protocols to culture ENS Progenitor Cells (EPCs) from the fetal
and postnatal mouse gut. Clonal analysis of such EPCs has
established that they represent self-renewing multilineage pro-
genitors capable of generating both neurons and glial cells. In-
terestingly, EPCs can also be generated from Ret51 mutant mice,
raising the possibility that they can be used in an autotrans-
plantation assay to replenish the agagnlionic gut segments with
ENS progenitors. To examine these possibilities we have been
transplanting EPCs into the wall of gut maintained in organotypic
cultures or in vivo. I will describe our efforts to maximize the
efﬁciency with which we obtain EPCs from embryonic and
postnatal gut and report on our preliminary studies on the trans-
plantation of EPCs into the gut wall with the ultimate aim of
restoring a functional ENS.
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Heart failure (HF) results from heart tissue having limited regen-
erative capacity following a heart attack. At end stage of HF, heart
transplantation is the only option. However, donor shortages leave
cell therapy, including tissue engineering solutions, as alternative
strategies. In our approach preformed patches of myocardial cells
are attached to a biodegradable engineered biomaterial support
using embryonic stem cell (ESC)-derived cardiomyocytes (ESC-
CM). We report on the characterisation of a series of biodegrad-
able elastomeric materials describing also tests carried out to
demonstrate their biocompatibility with cells, including ESC-CM.
Multiblock copolymers containing 30wt% hard segments of
poly(ethylene terephthalate) (PET) or poly(butylene terephthalate)
and 70wt% soft segments composed of dilinoleic acid (DLA) or
poly(ethylene glycol) were selected. Additionally, PET/DLA co-
polymers were used for preparation of composites containing
0.2wt% of titania nanopowder with the aim to induce nanotopo-
graphic features. D3 mouse ESC line (from ATCC) and human
ESC H7 (from Geron Corp) that were induced to differentiate via
embryoid body formation started to beat spontaneously from day
7 and day 9–12 onwards, respectively. All materials tested were
biocompatible with differentiating cardiac cells, which did not
show any signs of cytotoxicity or adverse effects. This was evi-
denced by the continuous beating of the cardiomyocyte clusters
for more than 35 days on these materials. It was noted that iso-
lated cells adhered and spread well on all materials tested even in
the absence of gelatin, and the presence of TiO2 nanoparticles was
not toxic to the cells but encouraged their adhesion, spread and
proliferation.
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The aim of this study was to develop a bone tissue engineering
scaffold with an inherent bone morphogenetic proteins BMP-2
and BMP-7 sequential delivery system. BMPs were encapsulated
in poly(3-hydroxybutyrate-co-3-hydroxyvalerate) (PHBV) and
poly(lactic acid-co-glycolic acid) (PLGA) nano/microparticules
which are then introduced to a chitosan matrix by two methods:
embedding in the chitosan ﬁbers and then forming the scaffold or
by forming the chitosan scaffold and then introducing the nano/
microparticules.
Nano/microparticles loaded with BSA (model protein) or BMPs
were prepared by double emulsion/solvent evaporation technique.
The structure, encapsulation efﬁciency and BSA release were
studied. Chitosan-based ﬁber mesh scaffolds were prepared by wet
spinning. Incorporation of nano/microparticles into ﬁber mesh
scaffolds was achieved by two methods: incorporation within the
ﬁbers and by post-seeding. For incorporation within the ﬁbers,
particles were mixed with chitosan solution and wet spun as pre-
sented above. Post-seeding was obtained by adding a particle
suspension in dH2O onto the scaffold followed by the application
of vacuum-pressure cycle.
Among the particles prepared, 20% PLGA nano/micro spheres
and 20% PHBV nano/micro capsules were chosen as the rapid and
slow release components of the sequential delivery system, re-
spectively. Wet spun chitosan scaffolds produced from 4% chit-
osan (w/v) revealed smooth surfaces and used for further studies.
Presence of particles within the ﬁbers was shown by SEM analysis
for the ﬁrst incorporation method. Post-seeding did not inﬂuence
the ﬁnal release pattern, but suppressed the burst release. In-
corporation of BMP-2 and BMP-7 carrying particles and the effect
of GF release on MSCs are being studied.
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The cells in tissues receive key solid-phase signals from ex-
tracellular matrix (ECM) through interactions of their trans-
membrane recognition proteins with speciﬁc domains on ECM
molecules. Therefore, biomaterials to be used as scaffolds for
guided tissue regeneration should exhibit corresponding recog-
nizable structures, either as whole ECM molecules or their frag-
ments, typically peptides, on their surfaces. A number of evidence
shows that not only the presence but also, and most importantly,
the molecular organization of peptide ligands on the surface
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